Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee

Pediatric Blood and Cancer

Volumn 51, Issue 2, 2008, Pages 163-170

  Meyer, James S ^a,k   Nadel, Helen R ^b   Marina, Neyssa ^c   Womer, Richard B ^a   Brown, Kenneth L B ^b   Eary, J F ^d   Gorlick, Richard ^e   Grier, Holcombe E ^f   Randall, R Lor ^g   Lawlor, Elizabeth R ^h   Lessnick, Stephen L ^g   Schomberg, Paula J ⁱ   Kailo, Mark D ^j  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY OF UTAH   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ MAYO CLINIC   (United States)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

more..

Author keywords

Ewing sarcoma; Imaging; Osteosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE; GADOLINIUM; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC IMAGING; EWING SARCOMA; HISTOPATHOLOGY; HUMAN; LUNG METASTASIS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR BIOPSY; WHOLE BODY IMAGING; ARTICLE; BONE TUMOR; CHILD; COMPUTER ASSISTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE;

BONE NEOPLASMS; CHILD; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SARCOMA, EWING'S; TOMOGRAPHY, X-RAY COMPUTED;

EID: 45549089411     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21596     Document Type: Note

References (35)

1. Ries LAG, Eisner MP, Kosary CL, et al. editors. SEER Cancer Statistics Review, 1975-2002. Bethesda, MD: National Cancer Institute; (http://seer.cancer. gov/csr/1975_2002), 2005.
2. Meyer JS, Dormans JP. Differential diagnosis of pediatric musculoskeletal masses. Magn Reson Imaging Clin N Am 1998;6:561-577.
3. Panicek DM, Gatsonis C, Rosenthal DI, et al. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group. Radiology 1997;202:237-246.
4. Brisse H, Ollivier L, Edeline V, et al. Imaging of malignant tumours of the long bones in children: Monitoring response to neoadjuvant chemotherapy and preoperative assessment. Pediatr Radiol 2004;34:595-605.
5. Meyer JS, Mackenzie W. Malignant bone tumors and limb-salvage surgery in children. Pediatr Radiol 2004;34:606-613.
6. Meyers PA, Gorlick R. Osteosarcoma. Pediatr Clin North Am 1997;44:973-989.
7. Grier HE. The Ewing family of tumors. Pediatr Clin North Am 1997;44:991-1004.
8. Cohen M, Grosfeld J, Baehner R, et al. Lung CT for detection of metastases: Solid tissue neoplasms in children. Am J Roentgenol 1982;139:895-898.
9. Vanel D, Henry-Amar M, Lumbroso J, et al. Pulmonary evaluation of patients with osteosarcoma: Roles of standard radiography, tomography, CT, scintigraphy, and tomoscintigraphy. Am J Roentgenol 1984;143:519-523.
10. Herold CJ, Bankier AA, Fleischmann D. Lung metastases. Eur Radiol 1996;6:596-606.
11. Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001;12:1601-1604.
12. Grampp S, Bankier AA, Zoubek A, et al. Spiral CT of the lung in children with malignant extra-thoracic tumors: Distribution of benign vs. malignant nodules. Eur Radiol 2000;10:1318-1322.
13. EURO-E.W.I.N.G. Study Committee. EURO-E.W.I.N.G. 99 Study Manual - EUROpean Ewing Tumor Initiative of National Groups Ewing Tumor Studies 1999.
14. A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy Study Protocol.
15. Nadel HR. Nuclear oncology in children. In: Freeman LM, editor. Nuclear medicine annual. New York: Raven press; 1996.
16. Bastiaannet E, Groen H, Jager PL, et al. The value of FDG-PET in the detection, grading, and response to therapy of soft tissue and bone sarcomas: A systematic review and meta-analysis. Cancer Treat Rev 2004;30:83-101.
17. Volker T, Denecke T, Steffen I, et al. Positron emission tomography for staging of pediatric sarcoma patients: Results of a prospective multicenter trial. J Clin Oncol 2007;25:5435-5441.
18. Franzius C, Sciuk J, Daldrup-Link HE, et al. FDG-PET for detection of osseous metastases from malignant primary bone tumours: Comparison with bone scintigraphy. Eur J Nucl Med 2000;27:1305-1311.
19. Hawkins DS, Rajendran JG, Conrad EU III, et al. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-d-glucose positron emission tomography. Cancer 2000;94:3277-3284.
20. 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer 2007;49:901-905.
21. Douglas-Akinwande AC, Buckwalter KA, Rydberg J, et al. Multichannel CT: Evaluating the spine in post-operative patients with orthopedic hardware. Radiographics 2006;26:S97-S110.
22. Bal M, Spies L. Metal artifact reduction in CT using tissue class modeling and adaptive prefiltering. Med Phys 2006;33:2852-2859.
23. Viano AM, Gronemeyer SA, Haliloglu M, et al. Improved MR imaging for patients with metallic implants. Magn Reson Imag 2000;18:287-295.
24. Brenner DJ, Elliston CD, Hall EJ, et al. Estimated risks of radiation-induced fatal cancer from pediatric CT. Am J Roentgenol 2001;176:289-296.
25. Rice HE, Frush DP, Farmer D, et al. Review of radiation risks from computed tomography: Essentials for the pediatric surgeon. J Ped Surg 2007;42:603-607.
26. Herzog P, Rieger CT. Risk of cancer from diagnostic x-rays. Lancet 2004;363:340.
27. Brody AS, Frush DP, Huda W, et al. Radiation risk to children from computed tomography. Pediatrics 2007;120:677-682.
28. Manning D. The risk of cancer from radiography. Radiography 2004;10:171-172.
29. Berrington de Gonzalez AB, Darby S. Risk of cancer from diagnostic X-rays: Estimates for the UK and 14 other countries. Lancet 2004;363:345-351.
30. Amis ES, Butler PF, Applegate KE, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol 2007;4:272-284.
31. Kalra MK, Naz N, Rizzo SMR, et al. Computed tomography radiation dose optimization: Scanning protocols and clinical applications of automatic exposure control. Curr Probl Diagn Radiol 2005;34:171-181.
32. Briccoli A, Rocca M, Salone M, et al. Resection of recurrent pulmonary metastases in patients with recurrent osteosarcoma. Cancer 2005;104:1721-1725.
33. Kandioler D, Kromer E, Tucher H, et al. Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg 1998;65:909-912.
34. Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15 year experience in 789 patients treated at a single institution. Cancer 2006;106:1154-1161.
35. Papagelopoulos PJ, Galanis E, Vlastou C, et al. Current concepts in the evaluation and treatment of osteosarcoma. Orthopedics 2000;23:858-867.